Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy

Cryobiology

Volumn 71, Issue 1, 2015, Pages 161-163

  Chudasama, Dimple ^a   Rice, Alexandra ^a   Soppa, Gopal ^a   Anikin, Vladimir ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Circulating tumour cells; Endobronchial cryotherapy; Endobronchial tumours; ScreenCell

Indexed keywords

AGED; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CANCER STAGING; CELL COUNT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CRYOTHERAPY; DISTANT METASTASIS; ENDOBRONCHIAL CRYOTHERAPY; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MALE; OBSERVATIONAL STUDY; PALLIATIVE THERAPY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADVERSE EFFECTS; AIRWAY OBSTRUCTION; CRYOSURGERY; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM;

AGED; AIRWAY OBSTRUCTION; CELL COUNT; CRYOSURGERY; CRYOTHERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASTIC CELLS, CIRCULATING; PALLIATIVE CARE; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84937725844     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2015.06.001     Document Type: Article

References (9)

1. About Health: Lung Cancer Survival Rates by Type and Stage, 2015. http://lungcancer.about.com/od/whatislungcancer/a/lungcancersurvivalrates.htm.
2. Cancer Research UK, 2015. http://www.cancerresearchuk.org/about-cancer/type/lung-cancer/treatment/statistics-and-outlook-for-lung-cancer.
3. Consoli F., Grisanti S., Amoroso V., Almici C., Verardi R., Marini M., Simoncini E. Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial. Tumori 2011, 97:737-742.
4. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
5. Giuliano M., Giordano A., Jackson S., Hess K.R., De G.U., Mego M., Handy B.C., Ueno N.T., Alvarez R.H., De Laurentiis M., De P.S., Valero V., Hortobagyi G.N., Reuben J.M., Cristofanilli M. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res. 2011, 13:R67.
6. Hoshimoto S., Shingai T., Morton D.L., Kuo C., Faries M.B., Chong K., Elashoff D., Wang H.J., Elashoff R.M., Hoon D.S. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J. Clin. Oncol. 2012, 30:3819-3826.
7. Hou J.M., Krebs M., Ward T., Morris K., Sloane R., Blackhall F., Dive C. Circulating tumor cells, enumeration and beyond. Cancers (Basel) 2010, 2:1236-1250.
8. Krebs M.G., Sloane R., Priest L., Lancashire L., Hou J.M., Greystoke A., Ward T.H., Ferraldeschi R., Hughes A., Clack G., Ranson M., Dive C., Blackhall F.H. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J. Clin. Oncol. 2011, 29:1556-1563.
9. O'Flaherty J.D., Gray S., Richard D., Fennell D., O'Leary J.J., Blackhall F.H., O'Byrne K.J. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 2012, 76:19-25.